These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 3874804

  • 1. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
    Weizman Z, Forstner GG, Gaskin KJ, Kopelman H, Wong S, Durie PR.
    Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
    [Abstract] [Full Text] [Related]

  • 2. BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared.
    Bellentani S, Grisendi A, Rinaldi M, Bertolani P, Costa G, Agostini M, Mastella G, Balli F, Manenti F.
    Eur J Pediatr; 1984 Dec; 143(2):145-8. PubMed ID: 6335090
    [Abstract] [Full Text] [Related]

  • 3. Failure of p-aminobenzoic acid screening test to diagnose pancreatic insufficiency in Shwachman's syndrome.
    Kai H, Nose O, Harada T, Maki I, Tajiri H, Yabuuchi H.
    J Pediatr Gastroenterol Nutr; 1982 Dec; 1(3):445-8. PubMed ID: 6985261
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.
    Hubbard VS, Wolf RO, Lester LA, Egge AC.
    Dig Dis Sci; 1984 Oct; 29(10):881-9. PubMed ID: 6206989
    [Abstract] [Full Text] [Related]

  • 5. Colorimetric plasma assay for the bentiromide test (BT-PABA) for exocrine pancreatic insufficiency.
    Gharbo SA, Boyer JA, Williamson MJ.
    Anal Biochem; 1985 Jul; 148(1):228-32. PubMed ID: 3876041
    [Abstract] [Full Text] [Related]

  • 6. A noninvasive stable-isotope method to simultaneously assess pancreatic exocrine function and small bowel absorption.
    Deutsch JC, Santhosh-Kumar CR, Kolli VR.
    Am J Gastroenterol; 1995 Dec; 90(12):2182-5. PubMed ID: 8540512
    [Abstract] [Full Text] [Related]

  • 7. Bentiromide test is not affected in patients with small bowel disease or liver disease.
    Meyer BM, Campbell DR, Curington CW, Toskes PP.
    Pancreas; 1987 Dec; 2(1):44-7. PubMed ID: 3494995
    [Abstract] [Full Text] [Related]

  • 8. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
    Durie PR, Largman C, Brodrick JW, Johnson JH, Gaskin KJ, Forstner GG, Geokas MC.
    Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
    [Abstract] [Full Text] [Related]

  • 9. Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test.
    Koren G, Weizman Z, Forstner G, MacLeod SM, Durie PR.
    Dig Dis Sci; 1985 Oct; 30(10):928-32. PubMed ID: 3875462
    [Abstract] [Full Text] [Related]

  • 10. The bentiromide test using plasma p-aminobenzoic acid for diagnosing pancreatic insufficiency in young children. The effect of two different doses and a liquid meal.
    Laufer D, Cleghorn G, Forstner G, Ellis L, Koren G, Durie P.
    Gastroenterology; 1991 Jul; 101(1):207-13. PubMed ID: 2044909
    [Abstract] [Full Text] [Related]

  • 11. BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.
    Delchier JC, Soule JC.
    Gut; 1983 Apr; 24(4):318-25. PubMed ID: 6601041
    [Abstract] [Full Text] [Related]

  • 12. Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency?
    Lankisch PG, Brauneis J, Otto J, Göke B.
    Gastroenterology; 1986 Feb; 90(2):350-4. PubMed ID: 3484456
    [Abstract] [Full Text] [Related]

  • 13. Simplified oral pancreatic function test.
    Puntis JW, Berg JD, Buckley BM, Booth IW, McNeish AS.
    Arch Dis Child; 1988 Jul; 63(7):780-4. PubMed ID: 3261963
    [Abstract] [Full Text] [Related]

  • 14. The bentiromide test for pancreatic exocrine insufficiency.
    Toskes PP.
    Pharmacotherapy; 1984 Jul; 4(2):74-80. PubMed ID: 6371722
    [Abstract] [Full Text] [Related]

  • 15. Detection of pancreatic steatorrhea by oral pancreatic function tests.
    Lankisch PG, Otto J, Brauneis J, Hilgers R, Lembcke B.
    Dig Dis Sci; 1988 Oct; 33(10):1233-6. PubMed ID: 3262493
    [Abstract] [Full Text] [Related]

  • 16. Reliability of the Bz-Ty-PABA and the pancreolauryl test in the assessment of exocrine pancreatic function.
    Cavallini G, Piubello W, Brocco G, Vantini I, Angelini G, Benini L, Chech G, Marchiaro G, Dobrilla G, Bonoldi C.
    Digestion; 1983 Oct; 27(3):129-37. PubMed ID: 6605266
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
    Nousia-Arvanitakis S, Arvanitakis C, Desai N, Greenberger NJ.
    J Pediatr; 1978 May; 92(5):734-7. PubMed ID: 305953
    [Abstract] [Full Text] [Related]

  • 18. Exocrine pancreatic function as determined in a same-day test with use of bentiromide and p-aminosalicylic acid.
    Berg JD, Chesner IM, Allen-Narker RA, Buckley BM, Lawson N.
    Clin Chem; 1986 Jun; 32(6):1010-2. PubMed ID: 3486726
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of the one-day NBT-PABA/14C-PABA in the assessment of pancreatic exocrine insufficiency.
    Tanner AR, Fisher D, Ward C, Smith CL.
    Digestion; 1984 Jun; 29(1):42-6. PubMed ID: 6609857
    [Abstract] [Full Text] [Related]

  • 20. Bentiromide test using liquid-chromatographic measurement of p-aminobenzoic acid and its metabolites for diagnosing pancreatic insufficiency in childhood.
    Durie PR, Yung-Jato LY, Soldin SJ, Verjee Z, Ellis L.
    J Pediatr; 1992 Sep; 121(3):413-6. PubMed ID: 1517919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.